AI assistant
PAVmed Inc. — Director's Dealing 2021
Mar 19, 2021
35221_dirs_2021-03-19_5a69a3a2-5950-4c63-9c7f-0d8ddab003d8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2021-03-18
Reporting Person: Aklog Lishan (Director, Chairman and CEO, 10% Owner)
Reporting Person: Pavilion Venture Partners LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-18 | Common Stock | P | 7500 | $4.3098 | Acquired | 1105913 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2303 | Indirect |
| Common Stock | 2280 | Indirect |
| Common Stock | 4456570 | Indirect |
| Common Stock | 20000 | Indirect |
Footnotes
F1: Dr. Aklog is a member and sole manager of Pavilion Venture Partners LLC, and has sole voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein.
F2: Dr. Aklog is a co-manager of HCFP/AG LLC, and shares joint voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his pecuniary interest therein.